Insight on What Matters - So You Can Transform Your Business.
The healthy valuations achieved by sellers have been supported by lenders’ willingness to finance packaging acquisitions, with leverage multiples today sometimes surpassing 7.0x total debt / EBITDA.
We're excited to release ShareVault version 4.1 in the first week of April with a number of important updates based on input from our customers in investment banking, life sciences, legal and other professional sectors.
The one-hour session explores many of the nightmares often experienced during due diligence and how to avoid them.
Taking appropriate steps to instill quality control at each point in the process is the first step, but achieving quality across the discovery spectrum requires well-defined processes, solid documentation, strong collaboration capabilities and a means to measure results.
The Promise and Challenges of Antibody-Drug Conjugates (ADC) Antibody-drug conjugates, or ADCs, are a new class of highly potent biopharmaceutical drug that can ferry drugs into cancer cells while...
ShareVault 4.0.1, released today, includes important changes to permissioning and policies, as well as a number of other minor improvements.
Blockchain–Trends & Transactions Blockchain is quickly shaping out to be an established enterprise technology. There are new technologies and capabilities emerging almost daily, as well as new job...
In most M&A transactions, the parties arrive at a purchase price by multiplying the target company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) by an agreed-upon...
Precision medicine is a move away from a one-size-fits-all approach toward an approach with the goal to target the right treatments to the right patients at the right time.
ShareVault CEO Richard Andersen recently sat down with Matt Ferrari, the Chief Technology Officer at ClearDATA to discuss how the cloud can be used to protect, securely manage, and fully automate many healthcare applications, data and IT infrastructure.
Blog